Upgrade to SI Premium - Free Trial

Edesa Biotech (EDSA)

5.20 +0.26 (5.26%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/14/25 *Est.)

Latest Headlines

Edesa Biotech reports exploratory data on drug for kidney injury June 5, 2026 9:26 AM - StreetInsider Form 8-K Edesa Biotech, Inc. For: Jun 05 June 5, 2026 9:25 AM - SEC Filing Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury June 5, 2026 9:20 AM - Globe NewsWire Form 4 Edesa Biotech, Inc. For: Jun 01 Filed by: Nijhawan Pardeep June 1, 2026 5:00 PM - SEC Filing Form 4 Edesa Biotech, Inc. For: May 27 Filed by: Marshall Patrick May 29, 2026 5:03 PM - SEC Filing Form 4 Edesa Biotech, Inc. For: May 27 Filed by: MacDonald Sean Arthur May 29, 2026 5:02 PM - SEC Filing Form 4 Edesa Biotech, Inc. For: May 27 Filed by: Chypyha Joan May 29, 2026 5:02 PM - SEC Filing Form 4 Edesa Biotech, Inc. For: May 27 Filed by: Weiler Peter J. May 29, 2026 5:02 PM - SEC Filing Form 4 Edesa Biotech, Inc. For: May 27 Filed by: Brooks Michael J May 29, 2026 5:01 PM - SEC Filing Form 4 Edesa Biotech, Inc. For: May 27 Filed by: Sistilli Carlo May 29, 2026 5:01 PM - SEC Filing Form 4 Edesa Biotech, Inc. For: May 27 Filed by: Olson Charles V May 29, 2026 5:01 PM - SEC Filing Form 4 Edesa Biotech, Inc. For: May 27 Filed by: Nijhawan Pardeep May 29, 2026 5:01 PM - SEC Filing Form 4 Edesa Biotech, Inc. For: May 27 Filed by: Liu Da David May 29, 2026 5:00 PM - SEC Filing Form S-8 Edesa Biotech, Inc. May 29, 2026 4:43 PM - SEC Filing Form 8-K Edesa Biotech, Inc. For: May 27 May 29, 2026 4:16 PM - SEC Filing Edesa Biotech to present kidney injury drug data at European conference May 19, 2026 9:15 AM - StreetInsider Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference May 19, 2026 9:15 AM - Globe NewsWire Form SCHEDULE 13G/A Edesa Biotech, Inc. Filed by: Stonepine Capital Management, LLC May 15, 2026 5:19 PM - SEC Filing Form SCHEDULE 13G/A Edesa Biotech, Inc. Filed by: Nantahala Capital Management, LLC May 15, 2026 4:47 PM - SEC Filing Form SCHEDULE 13G/A Edesa Biotech, Inc. Filed by: Point72 Asset Management, L.P. May 15, 2026 4:33 PM - SEC Filing Form SCHEDULE 13G Edesa Biotech, Inc. Filed by: Rubric Capital Management LP May 15, 2026 4:06 PM - SEC Filing Form 8-K Edesa Biotech, Inc. For: May 13 May 15, 2026 9:09 AM - SEC Filing Form SCHEDULE 13G Edesa Biotech, Inc. Filed by: Sirenia Capital Management LP May 15, 2026 8:15 AM - SEC Filing Form 10-Q Edesa Biotech, Inc. For: Mar 31 May 14, 2026 4:51 PM - SEC Filing Form 8-K Edesa Biotech, Inc. For: May 14 May 14, 2026 4:40 PM - SEC Filing Edesa Biotech Reports Fiscal 2nd Quarter 2026 Results May 14, 2026 4:30 PM - Globe NewsWire Form 4 Edesa Biotech, Inc. For: May 01 Filed by: Nijhawan Pardeep May 1, 2026 9:02 PM - SEC Filing Form 4 Edesa Biotech, Inc. For: Apr 01 Filed by: Nijhawan Pardeep April 10, 2026 5:02 PM - SEC Filing Form ARS Edesa Biotech, Inc. For: Sep 30 April 3, 2026 4:35 PM - SEC Filing Form DEFA14A Edesa Biotech, Inc. April 3, 2026 4:33 PM - SEC Filing Form DEF 14A Edesa Biotech, Inc. For: May 27 April 3, 2026 4:32 PM - SEC Filing Edesa Biotech Invited for Oral Showcase at Respiratory Innovation Summit March 31, 2026 4:20 PM - Globe NewsWire Edesa Biotech Advances Vitiligo Program for Planned Mid-2026 Enrollment March 26, 2026 9:15 AM - Globe NewsWire Form SCHEDULE 13G Edesa Biotech, Inc. Filed by: PERCEPTIVE ADVISORS LLC March 16, 2026 4:00 PM - SEC Filing Full Article List